01 1Shandong Anxin Pharmaceutical
01 1TAZOBACTAM (TRIAZOLE PROCESS)
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-06
Pay. Date : 2022-04-14
DMF Number : 36268
Submission : 2022-05-23
Status : Active
Type : II
20
Shandong Anxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TAZOBACTAM (TRIAZOLE PROCESS), with a corresponding US DMF Number 36268.
Remarkably, this DMF maintains an Active status since its submission on May 23, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2023, and payment made on April 14, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
